Non-AML
¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡µÄÔ¤Õ×ÓÐʲô?
ÆäËû¼±ÐÔ°×Ѫ²¡£¨non-AMLºÍALL£©»¼Õ߸üÈÝÒ×ÐγÉѪ˨¡£Ö÷Òª»úÖÆ¿ÉÄÜÊÇ£º¢ÙÔÚ°×Ѫ²¡Ï¸°ûºÍÑ»·Ï¸°ûÍâÄÒÅÝ£¨ev£©Éϱí´ïµÄ×éÖ¯Òò×ÓºÍÆäËû´ÙÄý·Ö×Ó¡£¢Úϸ°ûÒò×ÓºÍÆäËû½éÖʵÄÊÍ·Å¿ÉÄܻᴥ·¢ÑªÐ¡°å½øÈëÒ»ÖÖ¡°³¬¼¤»î״̬¡±£¬´Ó¶ø¼ÓËÙÄýѪ[14]¡£¢Û»¯ÁÆÏà¹ØµÄ´óÁ¿Ï¸°ûËÀÍö¿É´Ù½øTFºÍϸ°ûÒò×ÓÊÍ·Å¡£¢ÜÖÐÐÔÁ£Ï¸°ûϸ°ûÍâÏÝ
Cancer Cell:ÖØ°õ!CARÓÐÍûÖÎÁƼ±ÐÔËèϵ°×Ѫ²¡!
CAR-Tϸ°ûÁÆ·¨ÓÐÍûͨ¹ý°ÐÏòCD70ÖÎÁƼ±ÐÔËèϵ°×Ѫ²¡£¨AML£©£¬ÂéÊ¡×ÜÒ½ÔºµÄÑо¿Í¨¹ýÓÅ»¯CAR½á¹¹ÔöÇ¿ÁËÆäÁÆÐ§£¬ÎªÁÙ´²¿ª·¢ÌṩÁËÒÀ¾Ý¡£Ò»¡¢Ñо¿±³¾°...
NECÔÚҽѧÉÏÊÇʲôÒâÒå
¹ÇËèÔʼϸ°û·Çºìϵϸ°û¼ÆÊý(nonerythroid cells)Ôʼϸ°û·Çºìϵϸ°û¼ÆÊý(NEC)ÊÇ1985ÄêFABÐ×÷×éAMLÐÞ¶©Õï¶Ï±ê×¼ÖÐΪÁ˼ø±ð AMLÓëMDS¶øÌá³öµÄ¡£...
ÇëÎÊʲôÊÇ¡°¼±ÐÔËèϵ°×Ѫ²¡(AML,·ÇM3)¡±?
²¢½þÈóµ½È«Éí¸÷×éÖ¯ÔàÆ÷ÖУ¬°éÓв»Í¬³Ì¶ÈµÄƶѪ¡¢³öѪ¡¢¸ÐȾ·¢ÈÈÒÔ¼°¹Ç÷ÀÌÛÍ´¡£³£¼ûµÄ°×Ѫ²¡Ä£ÐÍ A.ÓÕ·¢Ä£ÐÍ£»B.ÒÆÖ²Ä£ÐÍ£»C.»ùÒòÐÞÊÎÄ£ÐÍ¡£AML...ϸ°ûÖÐÏà¹Øµ°°×±í´ïˮƽ CD34+CD38¨CKG1aϸ°ûµÄ·ÖÑ¡ Á÷ʽϸ°ûÒÇ(FCM)¼ì²â·ÖÑ¡ËùµÃCD34+CD38¨CKG1a´¿¶È CCK8¼ì²âLSCs¼°Non-LSCsÔöÖ³ÄÜÁ¦ ...
ÄãºÃ,ÏëÎÊÒ»ÏÂ,AMLºÍANLLÓÐʲô - ÓÐÎʱشð
AMLÊǼ±ÐÔËèϵ°×Ѫ²¡£¬ANLLÊǼÇÐÔ·ÇÁܰÍϸ°û°×Ѫ²¡£¬Ö»ÊǽеÄÃû³Æ²»Ò»Ñù£¬ÆäʵһÖÖ¼²²¡¡£...AMLÊÇÖ¸acutemyelocyticleukemia£¬·ÒëΪ¼±ÐÔËèϸ°û°×Ѫ²¡¡£ANLLÊÇÖ¸acutenonlymphocyticleukemia£¬¼±ÐÔ·ÇÁܰÍϸ°û°×Ѫ²¡¡£ËûÃÇÊÇÏàͬµÄ¶«Î÷£¬Ö»ÊÇÃû³Æ²»Í¬¡£²¡Çé·ÖÎö£ºÄãºÃ£¬¾ÝÎÒ·ÖÎö´ó²¿·Ö²¡Àý¿¿¹ÇËè´©´ÌͿƬÖÐÔʼ...
ÁÙ´²¼ìÑé»ù´¡ÖÐnecÊÇʲô¼ò³Æ
ÁÙ´²¼ìÑé»ù´¡ÖÐneÊǹÇËèÔʼϸ°û·Çºìϵϸ°û¼ÆÊý(nonerythroid cells)µÄËõд¡£·Çºìϵϸ°û°Ù·Ö±È(non erythroid cell£¬NEC)£¬NECÊÇָȥ³ýÓк˺ì/...
¶¯ÎïÄ£ÐÍ(Ö×Áöƪ) | ¼±ÐÔËèϵ°×Ѫ²¡(AML)Ä£Ð͹¹½¨,ÖµµÃÊÕ²Ø...
AML¶¯ÎïÄ£Ð͹¹½¨¡ª¡ª¶¯ÎïÑ¡Ôñ³£Óö¯ÎСÊó£¨ÓÈÆäÊÇÃâÒßȱÏÝСÊó£¬ÈçSCIDСÊó¡¢NOD/SCIDСÊó¡¢NSGСÊ󣩺ʹóÊó¡£ÓÅÊÆ£ºSCIDСÊó£ºÈ±·¦TºÍBÁܰÍϸ°û£¬ÃâÒß...
ÈçºÎ¿´´ýcartϸ°ûÒ©Îï¹ú²ú»¯½ø³Ì?
ÕâÖÖ¿¹ÔÔÚAMLϸ°ûÉϵÄÊýÁ¿±ÈÔÚÕý³£¹ÇËèϸ°ûÉϵÄÊýÁ¿¶à¡£ÔÚ¶¯ÎïÄ£ÐÍÖУ¬½öʹÓÃCD70 CAR-Tϸ°û¶ÔAMLÊʶÈÓÐЧ£¬µ«½«ËüÓëÃÀ¹úʳƷҩƷ¹ÜÀí¾Ö£¨FDA...Ïà¹ØÑо¿½á¹û½üÆÚ·¢±íÔÚNature Biomedical EngineeringÆÚ¿¯ÉÏ£¬ÂÛÎıêÌâΪ¡°Rapid manufacturing of non-activated potent CAR T cells¡±¡£ÂÛÎÄͨѶ...
Сº¢ÎªÊ²Ã´»áµÃ°×Ѫ²¡?
(chronic lymphocytic leukemia,cll),¢Û¼±ÐÔÁ£Ï¸°ûÐÔ°×Ѫ²¡(acute myelocytic leukemia,aml)»ò¼±ÐÔ·ÇÁܰÍϸ°ûÐÔ°×Ѫ²¡(acute non-lymphocytic leukemia,anll),¢ÜÂýÐÔÁ£Ï¸°ûÐÔ°×Ѫ²¡(chronic...
1ȾɫÁ¼ºÃ2¹ÇËèÔöÉú¼«¶È»îÔ¾3Á£ÏµÔöÉú¼õµÍ
1ȾɫÁ¼ºÃ2¹ÇËèÔöÉú¼«¶È»îÔ¾3Á£ÏµÔöÉú¼õµÍ¼±ÐÔ·ÇÁܰÍϸ°û°×Ѫ²¡(acute nonlymphocytic leukemia£¬ANLL)ԼռС¶ù¼±ÐÔ°×Ѫ²¡µÄ25£¥×óÓÒ£¬¿É·¢ÉúÓÚÈκÎÄêÁ䣬ÎÞÃ÷ÏÔÄêÁäµÄ·¢²¡¸ß·å£¬ÄÐŮ֮¼äÎÞ...±í13 AMLµÄMIC·ÖÀࣺºËÐÍ-ÐÎ̬Ïà¹ØÐÔ(Second MIC£¬1988) ºËÐÍ¸Ä±ä ÆµÂÊ (£¥) £Æ£Á£ÂÑÇÐÍ ½¨ÒéµÄ£Í£É£ÃÃüÃû t(8£»21)(£ñ22£»q22) £±£² £Í£² £Í2...